Covid-19 Impact on Global Insulin Management System Market Insights, Forecast to 2026
Diabetes is a metabolic disease in which consist of elevated blood glucose levels over a prolonged period. It is caused due to either pancreas not able to produce enough insulin or cells of the body not responding to the insulin produced. Insulin management system helps to deliver the insulin to the body of the patient. A number of different types of insulin delivery products are available in the market which includes insulin pen injectors, needle and syringe, insulin jet injectors, implantable pumps, external insulin pumps, insulin patches, and others.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Insulin Management System market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Insulin Management System industry.
Based on our recent survey, we have several different scenarios about the Insulin Management System YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Insulin Management System will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Insulin Management System market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Insulin Management System market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Insulin Management System market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Production and Pricing Analyses
Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Insulin Management System market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Insulin Management System market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Insulin Management System market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Insulin Management System market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Insulin Management System market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Insulin Management System market.
The following manufacturers are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Insulin Management System market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Insulin Management System industry.
Based on our recent survey, we have several different scenarios about the Insulin Management System YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Insulin Management System will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Insulin Management System market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Insulin Management System market in terms of both revenue and volume.
Players, stakeholders, and other participants in the global Insulin Management System market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on sales (volume), revenue and forecast by each application segment in terms of sales and revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Production and Pricing Analyses
Readers are provided with deeper production analysis, import and export analysis, and pricing analysis for the global Insulin Management System market. As part of production analysis, the report offers accurate statistics and figures for production capacity, production volume by region, and global production and production by each type segment for the period 2015-2026.
In the pricing analysis section of the report, readers are provided with validated statistics and figures for price by manufacturer and price by region for the period 2015-2020 and price by each type segment for the period 2015-2026. The import and export analysis for the global Insulin Management System market has been provided based on region.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Insulin Management System market, covering important regions, viz, North America, Europe, China and Japan. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of volume for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Insulin Management System market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on sales by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Insulin Management System market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Insulin Management System market.
The following manufacturers are covered in this report:
- Abbott
- Accu-Chek
- Animas
- Bayer
- Bristol-Myers Squibb
- DexCom
- Eli Lilly
- Insulet Corp
- Johnson & Johnson
- LifeScan
- Medtronic
- Merck
- Microport
- Novartis
- Novo Nordisk
- Roche
- Sanofi-aventis
- SOOIL
- Takeda Pharmaceuticals
- Tandem Diabetes care
- Valeritas
- By Product Type
- By Mode of Action
- Hospital & Clinics
- Ambulatory Centers
- Other
1 STUDY COVERAGE
1.1 Insulin Management System Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Insulin Management System Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Insulin Management System Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Insulin Management System Market Size Growth Rate by Application
1.5.2 Hospital & Clinics
1.5.3 Ambulatory Centers
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Insulin Management System Industry Impact
1.6.1 How the Covid-19 is Affecting the Insulin Management System Industry
1.6.1.1 Insulin Management System Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Insulin Management System Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Insulin Management System Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Insulin Management System Market Size Estimates and Forecasts
2.1.1 Global Insulin Management System Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Insulin Management System Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Insulin Management System Production Estimates and Forecasts 2015-2026
2.2 Global Insulin Management System Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Insulin Management System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Insulin Management System Manufacturers Geographical Distribution
2.4 Key Trends for Insulin Management System Markets & Products
2.5 Primary Interviews with Key Insulin Management System Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Insulin Management System Manufacturers by Production Capacity
3.1.1 Global Top Insulin Management System Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Insulin Management System Manufacturers by Production (2015-2020)
3.1.3 Global Top Insulin Management System Manufacturers Market Share by Production
3.2 Global Top Insulin Management System Manufacturers by Revenue
3.2.1 Global Top Insulin Management System Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Insulin Management System Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Management System Revenue in 2019
3.3 Global Insulin Management System Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 INSULIN MANAGEMENT SYSTEM PRODUCTION BY REGIONS
4.1 Global Insulin Management System Historic Market Facts & Figures by Regions
4.1.1 Global Top Insulin Management System Regions by Production (2015-2020)
4.1.2 Global Top Insulin Management System Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Insulin Management System Production (2015-2020)
4.2.2 North America Insulin Management System Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Insulin Management System Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Insulin Management System Production (2015-2020)
4.3.2 Europe Insulin Management System Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Insulin Management System Import & Export (2015-2020)
4.4 China
4.4.1 China Insulin Management System Production (2015-2020)
4.4.2 China Insulin Management System Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Insulin Management System Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Insulin Management System Production (2015-2020)
4.5.2 Japan Insulin Management System Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Insulin Management System Import & Export (2015-2020)
5 INSULIN MANAGEMENT SYSTEM CONSUMPTION BY REGION
5.1 Global Top Insulin Management System Regions by Consumption
5.1.1 Global Top Insulin Management System Regions by Consumption (2015-2020)
5.1.2 Global Top Insulin Management System Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Insulin Management System Consumption by Application
5.2.2 North America Insulin Management System Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Insulin Management System Consumption by Application
5.3.2 Europe Insulin Management System Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Insulin Management System Consumption by Application
5.4.2 Asia Pacific Insulin Management System Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Insulin Management System Consumption by Application
5.5.2 Central & South America Insulin Management System Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Insulin Management System Consumption by Application
5.6.2 Middle East and Africa Insulin Management System Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Insulin Management System Market Size by Type (2015-2020)
6.1.1 Global Insulin Management System Production by Type (2015-2020)
6.1.2 Global Insulin Management System Revenue by Type (2015-2020)
6.1.3 Insulin Management System Price by Type (2015-2020)
6.2 Global Insulin Management System Market Forecast by Type (2021-2026)
6.2.1 Global Insulin Management System Production Forecast by Type (2021-2026)
6.2.2 Global Insulin Management System Revenue Forecast by Type (2021-2026)
6.2.3 Global Insulin Management System Price Forecast by Type (2021-2026)
6.3 Global Insulin Management System Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Insulin Management System Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Insulin Management System Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Abbott
8.1.1 Abbott Corporation Information
8.1.2 Abbott Overview and Its Total Revenue
8.1.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Abbott Product Description
8.1.5 Abbott Recent Development
8.2 Accu-Chek
8.2.1 Accu-Chek Corporation Information
8.2.2 Accu-Chek Overview and Its Total Revenue
8.2.3 Accu-Chek Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Accu-Chek Product Description
8.2.5 Accu-Chek Recent Development
8.3 Animas
8.3.1 Animas Corporation Information
8.3.2 Animas Overview and Its Total Revenue
8.3.3 Animas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Animas Product Description
8.3.5 Animas Recent Development
8.4 Bayer
8.4.1 Bayer Corporation Information
8.4.2 Bayer Overview and Its Total Revenue
8.4.3 Bayer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Bayer Product Description
8.4.5 Bayer Recent Development
8.5 Bristol-Myers Squibb
8.5.1 Bristol-Myers Squibb Corporation Information
8.5.2 Bristol-Myers Squibb Overview and Its Total Revenue
8.5.3 Bristol-Myers Squibb Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Bristol-Myers Squibb Product Description
8.5.5 Bristol-Myers Squibb Recent Development
8.6 DexCom
8.6.1 DexCom Corporation Information
8.6.2 DexCom Overview and Its Total Revenue
8.6.3 DexCom Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 DexCom Product Description
8.6.5 DexCom Recent Development
8.7 Eli Lilly
8.7.1 Eli Lilly Corporation Information
8.7.2 Eli Lilly Overview and Its Total Revenue
8.7.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Eli Lilly Product Description
8.7.5 Eli Lilly Recent Development
8.8 Insulet Corp
8.8.1 Insulet Corp Corporation Information
8.8.2 Insulet Corp Overview and Its Total Revenue
8.8.3 Insulet Corp Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Insulet Corp Product Description
8.8.5 Insulet Corp Recent Development
8.9 Johnson & Johnson
8.9.1 Johnson & Johnson Corporation Information
8.9.2 Johnson & Johnson Overview and Its Total Revenue
8.9.3 Johnson & Johnson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Johnson & Johnson Product Description
8.9.5 Johnson & Johnson Recent Development
8.10 LifeScan
8.10.1 LifeScan Corporation Information
8.10.2 LifeScan Overview and Its Total Revenue
8.10.3 LifeScan Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 LifeScan Product Description
8.10.5 LifeScan Recent Development
8.11 Medtronic
8.11.1 Medtronic Corporation Information
8.11.2 Medtronic Overview and Its Total Revenue
8.11.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Medtronic Product Description
8.11.5 Medtronic Recent Development
8.12 Merck
8.12.1 Merck Corporation Information
8.12.2 Merck Overview and Its Total Revenue
8.12.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Merck Product Description
8.12.5 Merck Recent Development
8.13 Microport
8.13.1 Microport Corporation Information
8.13.2 Microport Overview and Its Total Revenue
8.13.3 Microport Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Microport Product Description
8.13.5 Microport Recent Development
8.14 Novartis
8.14.1 Novartis Corporation Information
8.14.2 Novartis Overview and Its Total Revenue
8.14.3 Novartis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Novartis Product Description
8.14.5 Novartis Recent Development
8.15 Novo Nordisk
8.15.1 Novo Nordisk Corporation Information
8.15.2 Novo Nordisk Overview and Its Total Revenue
8.15.3 Novo Nordisk Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Novo Nordisk Product Description
8.15.5 Novo Nordisk Recent Development
8.16 Roche
8.16.1 Roche Corporation Information
8.16.2 Roche Overview and Its Total Revenue
8.16.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 Roche Product Description
8.16.5 Roche Recent Development
8.17 Sanofi-aventis
8.17.1 Sanofi-aventis Corporation Information
8.17.2 Sanofi-aventis Overview and Its Total Revenue
8.17.3 Sanofi-aventis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.17.4 Sanofi-aventis Product Description
8.17.5 Sanofi-aventis Recent Development
8.18 SOOIL
8.18.1 SOOIL Corporation Information
8.18.2 SOOIL Overview and Its Total Revenue
8.18.3 SOOIL Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.18.4 SOOIL Product Description
8.18.5 SOOIL Recent Development
8.19 Takeda Pharmaceuticals
8.19.1 Takeda Pharmaceuticals Corporation Information
8.19.2 Takeda Pharmaceuticals Overview and Its Total Revenue
8.19.3 Takeda Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.19.4 Takeda Pharmaceuticals Product Description
8.19.5 Takeda Pharmaceuticals Recent Development
8.20 Tandem Diabetes care
8.20.1 Tandem Diabetes care Corporation Information
8.20.2 Tandem Diabetes care Overview and Its Total Revenue
8.20.3 Tandem Diabetes care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.20.4 Tandem Diabetes care Product Description
8.20.5 Tandem Diabetes care Recent Development
8.21 Valeritas
8.21.1 Valeritas Corporation Information
8.21.2 Valeritas Overview and Its Total Revenue
8.21.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.21.4 Valeritas Product Description
8.21.5 Valeritas Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Insulin Management System Regions Forecast by Revenue (2021-2026)
9.2 Global Top Insulin Management System Regions Forecast by Production (2021-2026)
9.3 Key Insulin Management System Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 INSULIN MANAGEMENT SYSTEM CONSUMPTION FORECAST BY REGION
10.1 Global Insulin Management System Consumption Forecast by Region (2021-2026)
10.2 North America Insulin Management System Consumption Forecast by Region (2021-2026)
10.3 Europe Insulin Management System Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Insulin Management System Consumption Forecast by Region (2021-2026)
10.5 Latin America Insulin Management System Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Insulin Management System Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Insulin Management System Sales Channels
11.2.2 Insulin Management System Distributors
11.3 Insulin Management System Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL INSULIN MANAGEMENT SYSTEM STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 Insulin Management System Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top Insulin Management System Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global Insulin Management System Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Insulin Management System Market Size Growth Rate by Application
1.5.2 Hospital & Clinics
1.5.3 Ambulatory Centers
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Insulin Management System Industry Impact
1.6.1 How the Covid-19 is Affecting the Insulin Management System Industry
1.6.1.1 Insulin Management System Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Insulin Management System Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Insulin Management System Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Insulin Management System Market Size Estimates and Forecasts
2.1.1 Global Insulin Management System Revenue Estimates and Forecasts 2015-2026
2.1.2 Global Insulin Management System Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global Insulin Management System Production Estimates and Forecasts 2015-2026
2.2 Global Insulin Management System Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global Insulin Management System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global Insulin Management System Manufacturers Geographical Distribution
2.4 Key Trends for Insulin Management System Markets & Products
2.5 Primary Interviews with Key Insulin Management System Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top Insulin Management System Manufacturers by Production Capacity
3.1.1 Global Top Insulin Management System Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top Insulin Management System Manufacturers by Production (2015-2020)
3.1.3 Global Top Insulin Management System Manufacturers Market Share by Production
3.2 Global Top Insulin Management System Manufacturers by Revenue
3.2.1 Global Top Insulin Management System Manufacturers by Revenue (2015-2020)
3.2.2 Global Top Insulin Management System Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by Insulin Management System Revenue in 2019
3.3 Global Insulin Management System Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 INSULIN MANAGEMENT SYSTEM PRODUCTION BY REGIONS
4.1 Global Insulin Management System Historic Market Facts & Figures by Regions
4.1.1 Global Top Insulin Management System Regions by Production (2015-2020)
4.1.2 Global Top Insulin Management System Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America Insulin Management System Production (2015-2020)
4.2.2 North America Insulin Management System Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America Insulin Management System Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe Insulin Management System Production (2015-2020)
4.3.2 Europe Insulin Management System Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe Insulin Management System Import & Export (2015-2020)
4.4 China
4.4.1 China Insulin Management System Production (2015-2020)
4.4.2 China Insulin Management System Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China Insulin Management System Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan Insulin Management System Production (2015-2020)
4.5.2 Japan Insulin Management System Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan Insulin Management System Import & Export (2015-2020)
5 INSULIN MANAGEMENT SYSTEM CONSUMPTION BY REGION
5.1 Global Top Insulin Management System Regions by Consumption
5.1.1 Global Top Insulin Management System Regions by Consumption (2015-2020)
5.1.2 Global Top Insulin Management System Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America Insulin Management System Consumption by Application
5.2.2 North America Insulin Management System Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe Insulin Management System Consumption by Application
5.3.2 Europe Insulin Management System Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Insulin Management System Consumption by Application
5.4.2 Asia Pacific Insulin Management System Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America Insulin Management System Consumption by Application
5.5.2 Central & South America Insulin Management System Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa Insulin Management System Consumption by Application
5.6.2 Middle East and Africa Insulin Management System Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global Insulin Management System Market Size by Type (2015-2020)
6.1.1 Global Insulin Management System Production by Type (2015-2020)
6.1.2 Global Insulin Management System Revenue by Type (2015-2020)
6.1.3 Insulin Management System Price by Type (2015-2020)
6.2 Global Insulin Management System Market Forecast by Type (2021-2026)
6.2.1 Global Insulin Management System Production Forecast by Type (2021-2026)
6.2.2 Global Insulin Management System Revenue Forecast by Type (2021-2026)
6.2.3 Global Insulin Management System Price Forecast by Type (2021-2026)
6.3 Global Insulin Management System Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global Insulin Management System Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global Insulin Management System Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 Abbott
8.1.1 Abbott Corporation Information
8.1.2 Abbott Overview and Its Total Revenue
8.1.3 Abbott Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 Abbott Product Description
8.1.5 Abbott Recent Development
8.2 Accu-Chek
8.2.1 Accu-Chek Corporation Information
8.2.2 Accu-Chek Overview and Its Total Revenue
8.2.3 Accu-Chek Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Accu-Chek Product Description
8.2.5 Accu-Chek Recent Development
8.3 Animas
8.3.1 Animas Corporation Information
8.3.2 Animas Overview and Its Total Revenue
8.3.3 Animas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 Animas Product Description
8.3.5 Animas Recent Development
8.4 Bayer
8.4.1 Bayer Corporation Information
8.4.2 Bayer Overview and Its Total Revenue
8.4.3 Bayer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Bayer Product Description
8.4.5 Bayer Recent Development
8.5 Bristol-Myers Squibb
8.5.1 Bristol-Myers Squibb Corporation Information
8.5.2 Bristol-Myers Squibb Overview and Its Total Revenue
8.5.3 Bristol-Myers Squibb Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Bristol-Myers Squibb Product Description
8.5.5 Bristol-Myers Squibb Recent Development
8.6 DexCom
8.6.1 DexCom Corporation Information
8.6.2 DexCom Overview and Its Total Revenue
8.6.3 DexCom Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 DexCom Product Description
8.6.5 DexCom Recent Development
8.7 Eli Lilly
8.7.1 Eli Lilly Corporation Information
8.7.2 Eli Lilly Overview and Its Total Revenue
8.7.3 Eli Lilly Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Eli Lilly Product Description
8.7.5 Eli Lilly Recent Development
8.8 Insulet Corp
8.8.1 Insulet Corp Corporation Information
8.8.2 Insulet Corp Overview and Its Total Revenue
8.8.3 Insulet Corp Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Insulet Corp Product Description
8.8.5 Insulet Corp Recent Development
8.9 Johnson & Johnson
8.9.1 Johnson & Johnson Corporation Information
8.9.2 Johnson & Johnson Overview and Its Total Revenue
8.9.3 Johnson & Johnson Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Johnson & Johnson Product Description
8.9.5 Johnson & Johnson Recent Development
8.10 LifeScan
8.10.1 LifeScan Corporation Information
8.10.2 LifeScan Overview and Its Total Revenue
8.10.3 LifeScan Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 LifeScan Product Description
8.10.5 LifeScan Recent Development
8.11 Medtronic
8.11.1 Medtronic Corporation Information
8.11.2 Medtronic Overview and Its Total Revenue
8.11.3 Medtronic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 Medtronic Product Description
8.11.5 Medtronic Recent Development
8.12 Merck
8.12.1 Merck Corporation Information
8.12.2 Merck Overview and Its Total Revenue
8.12.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.12.4 Merck Product Description
8.12.5 Merck Recent Development
8.13 Microport
8.13.1 Microport Corporation Information
8.13.2 Microport Overview and Its Total Revenue
8.13.3 Microport Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.13.4 Microport Product Description
8.13.5 Microport Recent Development
8.14 Novartis
8.14.1 Novartis Corporation Information
8.14.2 Novartis Overview and Its Total Revenue
8.14.3 Novartis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.14.4 Novartis Product Description
8.14.5 Novartis Recent Development
8.15 Novo Nordisk
8.15.1 Novo Nordisk Corporation Information
8.15.2 Novo Nordisk Overview and Its Total Revenue
8.15.3 Novo Nordisk Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.15.4 Novo Nordisk Product Description
8.15.5 Novo Nordisk Recent Development
8.16 Roche
8.16.1 Roche Corporation Information
8.16.2 Roche Overview and Its Total Revenue
8.16.3 Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.16.4 Roche Product Description
8.16.5 Roche Recent Development
8.17 Sanofi-aventis
8.17.1 Sanofi-aventis Corporation Information
8.17.2 Sanofi-aventis Overview and Its Total Revenue
8.17.3 Sanofi-aventis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.17.4 Sanofi-aventis Product Description
8.17.5 Sanofi-aventis Recent Development
8.18 SOOIL
8.18.1 SOOIL Corporation Information
8.18.2 SOOIL Overview and Its Total Revenue
8.18.3 SOOIL Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.18.4 SOOIL Product Description
8.18.5 SOOIL Recent Development
8.19 Takeda Pharmaceuticals
8.19.1 Takeda Pharmaceuticals Corporation Information
8.19.2 Takeda Pharmaceuticals Overview and Its Total Revenue
8.19.3 Takeda Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.19.4 Takeda Pharmaceuticals Product Description
8.19.5 Takeda Pharmaceuticals Recent Development
8.20 Tandem Diabetes care
8.20.1 Tandem Diabetes care Corporation Information
8.20.2 Tandem Diabetes care Overview and Its Total Revenue
8.20.3 Tandem Diabetes care Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.20.4 Tandem Diabetes care Product Description
8.20.5 Tandem Diabetes care Recent Development
8.21 Valeritas
8.21.1 Valeritas Corporation Information
8.21.2 Valeritas Overview and Its Total Revenue
8.21.3 Valeritas Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.21.4 Valeritas Product Description
8.21.5 Valeritas Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top Insulin Management System Regions Forecast by Revenue (2021-2026)
9.2 Global Top Insulin Management System Regions Forecast by Production (2021-2026)
9.3 Key Insulin Management System Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 INSULIN MANAGEMENT SYSTEM CONSUMPTION FORECAST BY REGION
10.1 Global Insulin Management System Consumption Forecast by Region (2021-2026)
10.2 North America Insulin Management System Consumption Forecast by Region (2021-2026)
10.3 Europe Insulin Management System Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific Insulin Management System Consumption Forecast by Region (2021-2026)
10.5 Latin America Insulin Management System Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa Insulin Management System Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Insulin Management System Sales Channels
11.2.2 Insulin Management System Distributors
11.3 Insulin Management System Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL INSULIN MANAGEMENT SYSTEM STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. Insulin Management System Key Market Segments in This Study
Table 2. Ranking of Global Top Insulin Management System Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Management System Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. COVID-19 Impact Global Market: (Four Insulin Management System Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Insulin Management System Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Insulin Management System Players to Combat Covid-19 Impact
Table 11. Global Insulin Management System Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Insulin Management System Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Management System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Management System as of 2019)
Table 15. Insulin Management System Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Insulin Management System Product Offered
Table 17. Date of Manufacturers Enter into Insulin Management System Market
Table 18. Key Trends for Insulin Management System Markets & Products
Table 19. Main Points Interviewed from Key Insulin Management System Players
Table 20. Global Insulin Management System Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Insulin Management System Production Share by Manufacturers (2015-2020)
Table 22. Insulin Management System Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Insulin Management System Revenue Share by Manufacturers (2015-2020)
Table 24. Insulin Management System Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Insulin Management System Production by Regions (2015-2020) (K Units)
Table 27. Global Insulin Management System Production Market Share by Regions (2015-2020)
Table 28. Global Insulin Management System Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Insulin Management System Revenue Market Share by Regions (2015-2020)
Table 30. Key Insulin Management System Players in North America
Table 31. Import & Export of Insulin Management System in North America (K Units)
Table 32. Key Insulin Management System Players in Europe
Table 33. Import & Export of Insulin Management System in Europe (K Units)
Table 34. Key Insulin Management System Players in China
Table 35. Import & Export of Insulin Management System in China (K Units)
Table 36. Key Insulin Management System Players in Japan
Table 37. Import & Export of Insulin Management System in Japan (K Units)
Table 38. Global Insulin Management System Consumption by Regions (2015-2020) (K Units)
Table 39. Global Insulin Management System Consumption Market Share by Regions (2015-2020)
Table 40. North America Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 41. North America Insulin Management System Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 43. Europe Insulin Management System Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Insulin Management System Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Insulin Management System Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Insulin Management System Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Insulin Management System Consumption by Countries (2015-2020) (K Units)
Table 51. Global Insulin Management System Production by Type (2015-2020) (K Units)
Table 52. Global Insulin Management System Production Share by Type (2015-2020)
Table 53. Global Insulin Management System Revenue by Type (2015-2020) (Million US$)
Table 54. Global Insulin Management System Revenue Share by Type (2015-2020)
Table 55. Insulin Management System Price by Type 2015-2020 (USD/Unit)
Table 56. Global Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 57. Global Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 58. Global Insulin Management System Consumption Share by Application (2015-2020)
Table 59. Abbott Corporation Information
Table 60. Abbott Description and Major Businesses
Table 61. Abbott Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Abbott Product
Table 63. Abbott Recent Development
Table 64. Accu-Chek Corporation Information
Table 65. Accu-Chek Description and Major Businesses
Table 66. Accu-Chek Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. Accu-Chek Product
Table 68. Accu-Chek Recent Development
Table 69. Animas Corporation Information
Table 70. Animas Description and Major Businesses
Table 71. Animas Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Animas Product
Table 73. Animas Recent Development
Table 74. Bayer Corporation Information
Table 75. Bayer Description and Major Businesses
Table 76. Bayer Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bayer Product
Table 78. Bayer Recent Development
Table 79. Bristol-Myers Squibb Corporation Information
Table 80. Bristol-Myers Squibb Description and Major Businesses
Table 81. Bristol-Myers Squibb Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Bristol-Myers Squibb Product
Table 83. Bristol-Myers Squibb Recent Development
Table 84. DexCom Corporation Information
Table 85. DexCom Description and Major Businesses
Table 86. DexCom Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. DexCom Product
Table 88. DexCom Recent Development
Table 89. Eli Lilly Corporation Information
Table 90. Eli Lilly Description and Major Businesses
Table 91. Eli Lilly Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Eli Lilly Product
Table 93. Eli Lilly Recent Development
Table 94. Insulet Corp Corporation Information
Table 95. Insulet Corp Description and Major Businesses
Table 96. Insulet Corp Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Insulet Corp Product
Table 98. Insulet Corp Recent Development
Table 99. Johnson & Johnson Corporation Information
Table 100. Johnson & Johnson Description and Major Businesses
Table 101. Johnson & Johnson Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Johnson & Johnson Product
Table 103. Johnson & Johnson Recent Development
Table 104. LifeScan Corporation Information
Table 105. LifeScan Description and Major Businesses
Table 106. LifeScan Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. LifeScan Product
Table 108. LifeScan Recent Development
Table 109. Medtronic Corporation Information
Table 110. Medtronic Description and Major Businesses
Table 111. Medtronic Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Medtronic Product
Table 113. Medtronic Recent Development
Table 114. Merck Corporation Information
Table 115. Merck Description and Major Businesses
Table 116. Merck Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Merck Product
Table 118. Merck Recent Development
Table 119. Microport Corporation Information
Table 120. Microport Description and Major Businesses
Table 121. Microport Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Microport Product
Table 123. Microport Recent Development
Table 124. Novartis Corporation Information
Table 125. Novartis Description and Major Businesses
Table 126. Novartis Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Novartis Product
Table 128. Novartis Recent Development
Table 129. Novo Nordisk Corporation Information
Table 130. Novo Nordisk Description and Major Businesses
Table 131. Novo Nordisk Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Novo Nordisk Product
Table 133. Novo Nordisk Recent Development
Table 134. Roche Corporation Information
Table 135. Roche Description and Major Businesses
Table 136. Roche Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Roche Product
Table 138. Roche Recent Development
Table 139. Sanofi-aventis Corporation Information
Table 140. Sanofi-aventis Description and Major Businesses
Table 141. Sanofi-aventis Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Sanofi-aventis Product
Table 143. Sanofi-aventis Recent Development
Table 144. SOOIL Corporation Information
Table 145. SOOIL Description and Major Businesses
Table 146. SOOIL Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. SOOIL Product
Table 148. SOOIL Recent Development
Table 149. Takeda Pharmaceuticals Corporation Information
Table 150. Takeda Pharmaceuticals Description and Major Businesses
Table 151. Takeda Pharmaceuticals Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Takeda Pharmaceuticals Product
Table 153. Takeda Pharmaceuticals Recent Development
Table 154. Tandem Diabetes care Corporation Information
Table 155. Tandem Diabetes care Description and Major Businesses
Table 156. Tandem Diabetes care Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Tandem Diabetes care Product
Table 158. Tandem Diabetes care Recent Development
Table 159. Valeritas Corporation Information
Table 160. Valeritas Description and Major Businesses
Table 161. Valeritas Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Valeritas Product
Table 163. Valeritas Recent Development
Table 164. Global Insulin Management System Revenue Forecast by Region (2021-2026) (Million US$)
Table 165. Global Insulin Management System Production Forecast by Regions (2021-2026) (K Units)
Table 166. Global Insulin Management System Production Forecast by Type (2021-2026) (K Units)
Table 167. Global Insulin Management System Revenue Forecast by Type (2021-2026) (Million US$)
Table 168. North America Insulin Management System Consumption Forecast by Regions (2021-2026) (K Units)
Table 169. Europe Insulin Management System Consumption Forecast by Regions (2021-2026) (K Units)
Table 170. Asia Pacific Insulin Management System Consumption Forecast by Regions (2021-2026) (K Units)
Table 171. Latin America Insulin Management System Consumption Forecast by Regions (2021-2026) (K Units)
Table 172. Middle East and Africa Insulin Management System Consumption Forecast by Regions (2021-2026) (K Units)
Table 173. Insulin Management System Distributors List
Table 174. Insulin Management System Customers List
Table 175. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 176. Key Challenges
Table 177. Market Risks
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 1. Insulin Management System Key Market Segments in This Study
Table 2. Ranking of Global Top Insulin Management System Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Insulin Management System Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. COVID-19 Impact Global Market: (Four Insulin Management System Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for Insulin Management System Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for Insulin Management System Players to Combat Covid-19 Impact
Table 11. Global Insulin Management System Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global Insulin Management System Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insulin Management System by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Insulin Management System as of 2019)
Table 15. Insulin Management System Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers Insulin Management System Product Offered
Table 17. Date of Manufacturers Enter into Insulin Management System Market
Table 18. Key Trends for Insulin Management System Markets & Products
Table 19. Main Points Interviewed from Key Insulin Management System Players
Table 20. Global Insulin Management System Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global Insulin Management System Production Share by Manufacturers (2015-2020)
Table 22. Insulin Management System Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. Insulin Management System Revenue Share by Manufacturers (2015-2020)
Table 24. Insulin Management System Price by Manufacturers 2015-2020 (USD/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Insulin Management System Production by Regions (2015-2020) (K Units)
Table 27. Global Insulin Management System Production Market Share by Regions (2015-2020)
Table 28. Global Insulin Management System Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global Insulin Management System Revenue Market Share by Regions (2015-2020)
Table 30. Key Insulin Management System Players in North America
Table 31. Import & Export of Insulin Management System in North America (K Units)
Table 32. Key Insulin Management System Players in Europe
Table 33. Import & Export of Insulin Management System in Europe (K Units)
Table 34. Key Insulin Management System Players in China
Table 35. Import & Export of Insulin Management System in China (K Units)
Table 36. Key Insulin Management System Players in Japan
Table 37. Import & Export of Insulin Management System in Japan (K Units)
Table 38. Global Insulin Management System Consumption by Regions (2015-2020) (K Units)
Table 39. Global Insulin Management System Consumption Market Share by Regions (2015-2020)
Table 40. North America Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 41. North America Insulin Management System Consumption by Countries (2015-2020) (K Units)
Table 42. Europe Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 43. Europe Insulin Management System Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific Insulin Management System Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific Insulin Management System Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 48. Latin America Insulin Management System Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa Insulin Management System Consumption by Countries (2015-2020) (K Units)
Table 51. Global Insulin Management System Production by Type (2015-2020) (K Units)
Table 52. Global Insulin Management System Production Share by Type (2015-2020)
Table 53. Global Insulin Management System Revenue by Type (2015-2020) (Million US$)
Table 54. Global Insulin Management System Revenue Share by Type (2015-2020)
Table 55. Insulin Management System Price by Type 2015-2020 (USD/Unit)
Table 56. Global Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 57. Global Insulin Management System Consumption by Application (2015-2020) (K Units)
Table 58. Global Insulin Management System Consumption Share by Application (2015-2020)
Table 59. Abbott Corporation Information
Table 60. Abbott Description and Major Businesses
Table 61. Abbott Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 62. Abbott Product
Table 63. Abbott Recent Development
Table 64. Accu-Chek Corporation Information
Table 65. Accu-Chek Description and Major Businesses
Table 66. Accu-Chek Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 67. Accu-Chek Product
Table 68. Accu-Chek Recent Development
Table 69. Animas Corporation Information
Table 70. Animas Description and Major Businesses
Table 71. Animas Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 72. Animas Product
Table 73. Animas Recent Development
Table 74. Bayer Corporation Information
Table 75. Bayer Description and Major Businesses
Table 76. Bayer Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Bayer Product
Table 78. Bayer Recent Development
Table 79. Bristol-Myers Squibb Corporation Information
Table 80. Bristol-Myers Squibb Description and Major Businesses
Table 81. Bristol-Myers Squibb Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Bristol-Myers Squibb Product
Table 83. Bristol-Myers Squibb Recent Development
Table 84. DexCom Corporation Information
Table 85. DexCom Description and Major Businesses
Table 86. DexCom Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. DexCom Product
Table 88. DexCom Recent Development
Table 89. Eli Lilly Corporation Information
Table 90. Eli Lilly Description and Major Businesses
Table 91. Eli Lilly Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Eli Lilly Product
Table 93. Eli Lilly Recent Development
Table 94. Insulet Corp Corporation Information
Table 95. Insulet Corp Description and Major Businesses
Table 96. Insulet Corp Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Insulet Corp Product
Table 98. Insulet Corp Recent Development
Table 99. Johnson & Johnson Corporation Information
Table 100. Johnson & Johnson Description and Major Businesses
Table 101. Johnson & Johnson Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Johnson & Johnson Product
Table 103. Johnson & Johnson Recent Development
Table 104. LifeScan Corporation Information
Table 105. LifeScan Description and Major Businesses
Table 106. LifeScan Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. LifeScan Product
Table 108. LifeScan Recent Development
Table 109. Medtronic Corporation Information
Table 110. Medtronic Description and Major Businesses
Table 111. Medtronic Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Medtronic Product
Table 113. Medtronic Recent Development
Table 114. Merck Corporation Information
Table 115. Merck Description and Major Businesses
Table 116. Merck Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Merck Product
Table 118. Merck Recent Development
Table 119. Microport Corporation Information
Table 120. Microport Description and Major Businesses
Table 121. Microport Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Microport Product
Table 123. Microport Recent Development
Table 124. Novartis Corporation Information
Table 125. Novartis Description and Major Businesses
Table 126. Novartis Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Novartis Product
Table 128. Novartis Recent Development
Table 129. Novo Nordisk Corporation Information
Table 130. Novo Nordisk Description and Major Businesses
Table 131. Novo Nordisk Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Novo Nordisk Product
Table 133. Novo Nordisk Recent Development
Table 134. Roche Corporation Information
Table 135. Roche Description and Major Businesses
Table 136. Roche Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Roche Product
Table 138. Roche Recent Development
Table 139. Sanofi-aventis Corporation Information
Table 140. Sanofi-aventis Description and Major Businesses
Table 141. Sanofi-aventis Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 142. Sanofi-aventis Product
Table 143. Sanofi-aventis Recent Development
Table 144. SOOIL Corporation Information
Table 145. SOOIL Description and Major Businesses
Table 146. SOOIL Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 147. SOOIL Product
Table 148. SOOIL Recent Development
Table 149. Takeda Pharmaceuticals Corporation Information
Table 150. Takeda Pharmaceuticals Description and Major Businesses
Table 151. Takeda Pharmaceuticals Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 152. Takeda Pharmaceuticals Product
Table 153. Takeda Pharmaceuticals Recent Development
Table 154. Tandem Diabetes care Corporation Information
Table 155. Tandem Diabetes care Description and Major Businesses
Table 156. Tandem Diabetes care Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 157. Tandem Diabetes care Product
Table 158. Tandem Diabetes care Recent Development
Table 159. Valeritas Corporation Information
Table 160. Valeritas Description and Major Businesses
Table 161. Valeritas Insulin Management System Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Valeritas Product
Table 163. Valeritas Recent Development
Table 164. Global Insulin Management System Revenue Forecast by Region (2021-2026) (Million US$)
Table 165. Global Insulin Management System Production Forecast by Regions (2021-2026) (K Units)
Table 166. Global Insulin Management System Production Forecast by Type (2021-2026) (K Units)
Table 167. Global Insulin Management System Revenue Forecast by Type (2021-2026) (Million US$)
Table 168. North America Insulin Management System Consumption Forecast by Regions (2021-2026) (K Units)
Table 169. Europe Insulin Management System Consumption Forecast by Regions (2021-2026) (K Units)
Table 170. Asia Pacific Insulin Management System Consumption Forecast by Regions (2021-2026) (K Units)
Table 171. Latin America Insulin Management System Consumption Forecast by Regions (2021-2026) (K Units)
Table 172. Middle East and Africa Insulin Management System Consumption Forecast by Regions (2021-2026) (K Units)
Table 173. Insulin Management System Distributors List
Table 174. Insulin Management System Customers List
Table 175. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 176. Key Challenges
Table 177. Market Risks
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Insulin Management System Product Picture
Figure 2. Global Insulin Management System Production Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Insulin Management System Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospital & Clinics
Figure 7. Ambulatory Centers
Figure 8. Other
Figure 9. Insulin Management System Report Years Considered
Figure 10. Global Insulin Management System Revenue 2015-2026 (Million US$)
Figure 11. Global Insulin Management System Production Capacity 2015-2026 (K Units)
Figure 12. Global Insulin Management System Production 2015-2026 (K Units)
Figure 13. Global Insulin Management System Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 14. Insulin Management System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Insulin Management System Production Share by Manufacturers in 2015
Figure 16. The Top 10 and Top 5 Players Market Share by Insulin Management System Revenue in 2019
Figure 17. Global Insulin Management System Production Market Share by Region (2015-2020)
Figure 18. Insulin Management System Production Growth Rate in North America (2015-2020) (K Units)
Figure 19. Insulin Management System Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 20. Insulin Management System Production Growth Rate in Europe (2015-2020) (K Units)
Figure 21. Insulin Management System Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 22. Insulin Management System Production Growth Rate in China (2015-2020) (K Units)
Figure 23. Insulin Management System Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 24. Insulin Management System Production Growth Rate in Japan (2015-2020) (K Units)
Figure 25. Insulin Management System Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 26. Global Insulin Management System Consumption Market Share by Regions 2015-2020
Figure 27. North America Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 28. North America Insulin Management System Consumption Market Share by Application in 2019
Figure 29. North America Insulin Management System Consumption Market Share by Countries in 2019
Figure 30. U.S. Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Canada Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Insulin Management System Consumption Market Share by Application in 2019
Figure 34. Europe Insulin Management System Consumption Market Share by Countries in 2019
Figure 35. Germany Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. France Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. U.K. Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Italy Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Russia Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Asia Pacific Insulin Management System Consumption and Growth Rate (K Units)
Figure 41. Asia Pacific Insulin Management System Consumption Market Share by Application in 2019
Figure 42. Asia Pacific Insulin Management System Consumption Market Share by Regions in 2019
Figure 43. China Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Japan Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. India Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Australia Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Taiwan Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Indonesia Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Thailand Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Malaysia Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Philippines Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Vietnam Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Latin America Insulin Management System Consumption and Growth Rate (K Units)
Figure 55. Latin America Insulin Management System Consumption Market Share by Application in 2019
Figure 56. Latin America Insulin Management System Consumption Market Share by Countries in 2019
Figure 57. Mexico Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Brazil Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Argentina Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Middle East and Africa Insulin Management System Consumption and Growth Rate (K Units)
Figure 61. Middle East and Africa Insulin Management System Consumption Market Share by Application in 2019
Figure 62. Middle East and Africa Insulin Management System Consumption Market Share by Countries in 2019
Figure 63. Turkey Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Saudi Arabia Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. U.A.E Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Global Insulin Management System Production Market Share by Type (2015-2020)
Figure 67. Global Insulin Management System Production Market Share by Type in 2019
Figure 68. Global Insulin Management System Revenue Market Share by Type (2015-2020)
Figure 69. Global Insulin Management System Revenue Market Share by Type in 2019
Figure 70. Global Insulin Management System Production Market Share Forecast by Type (2021-2026)
Figure 71. Global Insulin Management System Revenue Market Share Forecast by Type (2021-2026)
Figure 72. Global Insulin Management System Market Share by Price Range (2015-2020)
Figure 73. Global Insulin Management System Consumption Market Share by Application (2015-2020)
Figure 74. Global Insulin Management System Value (Consumption) Market Share by Application (2015-2020)
Figure 75. Global Insulin Management System Consumption Market Share Forecast by Application (2021-2026)
Figure 76. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Accu-Chek Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Animas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. DexCom Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Insulet Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. LifeScan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Microport Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Sanofi-aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. SOOIL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Takeda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Tandem Diabetes care Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Valeritas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Global Insulin Management System Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 98. Global Insulin Management System Revenue Market Share Forecast by Regions ((2021-2026))
Figure 99. Global Insulin Management System Production Forecast by Regions (2021-2026) (K Units)
Figure 100. North America Insulin Management System Production Forecast (2021-2026) (K Units)
Figure 101. North America Insulin Management System Revenue Forecast (2021-2026) (US$ Million)
Figure 102. Europe Insulin Management System Production Forecast (2021-2026) (K Units)
Figure 103. Europe Insulin Management System Revenue Forecast (2021-2026) (US$ Million)
Figure 104. China Insulin Management System Production Forecast (2021-2026) (K Units)
Figure 105. China Insulin Management System Revenue Forecast (2021-2026) (US$ Million)
Figure 106. Japan Insulin Management System Production Forecast (2021-2026) (K Units)
Figure 107. Japan Insulin Management System Revenue Forecast (2021-2026) (US$ Million)
Figure 108. Global Insulin Management System Consumption Market Share Forecast by Region (2021-2026)
Figure 109. Insulin Management System Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
Figure 1. Insulin Management System Product Picture
Figure 2. Global Insulin Management System Production Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Insulin Management System Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospital & Clinics
Figure 7. Ambulatory Centers
Figure 8. Other
Figure 9. Insulin Management System Report Years Considered
Figure 10. Global Insulin Management System Revenue 2015-2026 (Million US$)
Figure 11. Global Insulin Management System Production Capacity 2015-2026 (K Units)
Figure 12. Global Insulin Management System Production 2015-2026 (K Units)
Figure 13. Global Insulin Management System Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 14. Insulin Management System Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global Insulin Management System Production Share by Manufacturers in 2015
Figure 16. The Top 10 and Top 5 Players Market Share by Insulin Management System Revenue in 2019
Figure 17. Global Insulin Management System Production Market Share by Region (2015-2020)
Figure 18. Insulin Management System Production Growth Rate in North America (2015-2020) (K Units)
Figure 19. Insulin Management System Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 20. Insulin Management System Production Growth Rate in Europe (2015-2020) (K Units)
Figure 21. Insulin Management System Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 22. Insulin Management System Production Growth Rate in China (2015-2020) (K Units)
Figure 23. Insulin Management System Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 24. Insulin Management System Production Growth Rate in Japan (2015-2020) (K Units)
Figure 25. Insulin Management System Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 26. Global Insulin Management System Consumption Market Share by Regions 2015-2020
Figure 27. North America Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 28. North America Insulin Management System Consumption Market Share by Application in 2019
Figure 29. North America Insulin Management System Consumption Market Share by Countries in 2019
Figure 30. U.S. Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Canada Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe Insulin Management System Consumption Market Share by Application in 2019
Figure 34. Europe Insulin Management System Consumption Market Share by Countries in 2019
Figure 35. Germany Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. France Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. U.K. Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Italy Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Russia Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Asia Pacific Insulin Management System Consumption and Growth Rate (K Units)
Figure 41. Asia Pacific Insulin Management System Consumption Market Share by Application in 2019
Figure 42. Asia Pacific Insulin Management System Consumption Market Share by Regions in 2019
Figure 43. China Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Japan Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. South Korea Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. India Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Australia Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Taiwan Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Indonesia Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Thailand Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Malaysia Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Philippines Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Vietnam Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Latin America Insulin Management System Consumption and Growth Rate (K Units)
Figure 55. Latin America Insulin Management System Consumption Market Share by Application in 2019
Figure 56. Latin America Insulin Management System Consumption Market Share by Countries in 2019
Figure 57. Mexico Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Brazil Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Argentina Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Middle East and Africa Insulin Management System Consumption and Growth Rate (K Units)
Figure 61. Middle East and Africa Insulin Management System Consumption Market Share by Application in 2019
Figure 62. Middle East and Africa Insulin Management System Consumption Market Share by Countries in 2019
Figure 63. Turkey Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Saudi Arabia Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. U.A.E Insulin Management System Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Global Insulin Management System Production Market Share by Type (2015-2020)
Figure 67. Global Insulin Management System Production Market Share by Type in 2019
Figure 68. Global Insulin Management System Revenue Market Share by Type (2015-2020)
Figure 69. Global Insulin Management System Revenue Market Share by Type in 2019
Figure 70. Global Insulin Management System Production Market Share Forecast by Type (2021-2026)
Figure 71. Global Insulin Management System Revenue Market Share Forecast by Type (2021-2026)
Figure 72. Global Insulin Management System Market Share by Price Range (2015-2020)
Figure 73. Global Insulin Management System Consumption Market Share by Application (2015-2020)
Figure 74. Global Insulin Management System Value (Consumption) Market Share by Application (2015-2020)
Figure 75. Global Insulin Management System Consumption Market Share Forecast by Application (2021-2026)
Figure 76. Abbott Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Accu-Chek Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. Animas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. DexCom Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Insulet Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. LifeScan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Microport Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Sanofi-aventis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. SOOIL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Takeda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Tandem Diabetes care Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Valeritas Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Global Insulin Management System Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 98. Global Insulin Management System Revenue Market Share Forecast by Regions ((2021-2026))
Figure 99. Global Insulin Management System Production Forecast by Regions (2021-2026) (K Units)
Figure 100. North America Insulin Management System Production Forecast (2021-2026) (K Units)
Figure 101. North America Insulin Management System Revenue Forecast (2021-2026) (US$ Million)
Figure 102. Europe Insulin Management System Production Forecast (2021-2026) (K Units)
Figure 103. Europe Insulin Management System Revenue Forecast (2021-2026) (US$ Million)
Figure 104. China Insulin Management System Production Forecast (2021-2026) (K Units)
Figure 105. China Insulin Management System Revenue Forecast (2021-2026) (US$ Million)
Figure 106. Japan Insulin Management System Production Forecast (2021-2026) (K Units)
Figure 107. Japan Insulin Management System Revenue Forecast (2021-2026) (US$ Million)
Figure 108. Global Insulin Management System Consumption Market Share Forecast by Region (2021-2026)
Figure 109. Insulin Management System Value Chain
Figure 110. Channels of Distribution
Figure 111. Distributors Profiles
Figure 112. Porter's Five Forces Analysis
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
